Filing Details
- Accession Number:
- 0001144204-16-088987
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-18 18:01:55
- Reporting Period:
- 2016-03-16
- Filing Date:
- 2016-03-18
- Accepted Time:
- 2016-03-18 18:01:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133869 | Capricor Therapeutics Inc. | CAPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604726 | Edward St. John, Llc | 2560 Lord Baltimore Drive Baltimore MD 21244 | No | No | Yes | No | |
1604736 | A. Edward John St. | 2560 Lord Baltimore Drive Baltimore MD 21244 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-16 | 416,666 | $2.40 | 842,439 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-03-16 | 416,666 | $2.40 | 842,439 | No | 4 | P | Indirect | By Edward St. John, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By Edward St. John, LLC |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2016-03-16 | 208,333 | $0.00 | 208,333 | $4.50 |
Common Stock | Warrant | Acquisiton | 2016-03-16 | 208,333 | $0.00 | 208,333 | $4.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
208,333 | 2016-09-17 | 2019-03-16 | No | 4 | P | Direct |
208,333 | 2016-09-17 | 2019-03-16 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,556,141 | Indirect | By MD BTI, LLC |
Common Stock | 1,556,141 | Indirect | By MD BTI, LLC |
Common Stock | 54,602 | Direct | |
Common Stock | 324,196 | Indirect | By MD BTI, Inc. |
Footnotes
- This Form 4 is filed jointly by Edward A. St. John and Edward St. John, LLC ("St. John LLC"). The shares and warrants reported here are owned directly by St. John LLC.
- St. John LLC entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which St. John LLC, on March 16, 2016, purchased an aggregate of 416,666 shares of the Issuer's common stock at a purchase price of $2.40 per share for an aggregate purchase price of approximately US$1,000,000. In connection with the purchase of shares, St. John LLC also received a warrant to purchase up to 208,333 shares of the Issuer's common stock at a strike price of $4.50 per share, exercisable at any time between September 17, 2016 and March 16, 2019.
- The shares reported here are owned indirectly by St. John LLC.
- Mr. St. John is the sole member and general manager of St. John LLC. Accordingly, Mr. St. John is the indirect beneficial owner of the shares and warrants reported here. Mr. St. John disclaims beneficial ownership of these shares and warrants except to the extent of his pecuniary interest in the shares and warrants.
- The shares reported here are owned indirectly by Mr. St. John.
- The shares reported here are owned directly by Mr. St. John.
- Thee shares reported here are owned indirectly by Mr. St. John.